Veraxa Biotech is trading at $2.10 (+6.06%) on July 29, 2026, amid a volatile two-day rebound following a prior pullback.

  • The move appears consistent with short-term trading volatility and broader biotech sentiment rather than a specific company announcement or fundamental driver.
  • Intraday strength suggests significant rebound buying after recent swings, even as the broader biotech sector remains under pressure.